News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Carly Guenther

Advertisement

Articles by Carly Guenther

In Blockchain We Trust

ByCarly Guenther
October 29th 2018

Pharmaceutical Executive

The next generation of supply chain shows an increasing need for blockchain technology.

Advertisement

Latest Updated Articles

  • In Blockchain We Trust
    In Blockchain We Trust

    October 29th 2018



Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics

2

President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs

3

Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff

4

Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics

5

Addressing Regulatory Issues and the Biosimilar Void: Q&A with Thomas Newcomer

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us